Adipose-derived mesenchymal stem cells in systemic sclerosis: a review of recent advances and prospection
Abstract：Mesenchymal/stromal stem cells (MSCs) are nonhematopoietic multipotent progenitor cells.More recently,the discovery of MSCs immunomodulatory,angiogenic and antifibrotic capabilities properties made MSCs-based therapy progressively slips from the field of regenerative medicine to autoimmunity.Adipose mesenchymal stem cells (ASCs) are MSCs derived from fat.In this article,we review the current research status of MSCs in systemic sclerosis (SSc,Scleroderma),and expound the feasibility of clinical application of ASCs in the treatment of SSc.
Keywords：Mesenchymal stem cells (MSCs)Adipose mesenchymal stem cells (ASCs)Bone marrow mesenchymal stem cells (BM-MSCs)Systemic sclerosis (SSc)
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 296-298 )